EP3716979
Samsetning af 4-pýrimídínsúlfamíð-afleiðu með SGLT-2 hindra til meðhöndlunar á endóþelín-tengdum sjúkdómum
:
EP einkaleyfi í gildi á Íslandi:
29.11.2018:
9.4.2025:
18814821.7
:
25.6.2025:
15.7.2025
:
28.11.2038:
28.11.2025
:
COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES
29.11.2018
9.4.2025
25.6.2025
15.7.2025
28.11.2025
:
Idorsia Pharmaceuticals Ltd:
Hegenheimermattweg 91, 4123 Allschwil, CH
:
BELLET, Marc:
4123 Allschwil, CH
:
IGLARZ, Marc:
4123 Allschwil, CH
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
PCT/EP2017/081050:
30.11.2017:
WO
:
EP2018082947:
29.11.2018
:
A61K 31/506, A61K 31/70, A61K 31/7042, A61K 31/7048, A61K 31/7056, A61P 9/10, A61P 17/02, A61P 13/12, A61P 9/12, A61P 3/10